zdorПроблемы здоровья и экологииHealth and Ecology Issues2220-09672708-6011Gomel State Medical University10.51523/2708-6011.2007-4-3-1zdor-559Research ArticleКЛИНИЧЕСКАЯ МЕДИЦИНАCLINICAL MEDICINEЭНДОВАСКУЛЯРНЫЕ МЕТОДЫ ЛЕЧЕНИЯ БОЛЬНЫХ СО СТЕНОЗИРУЮЩИМ АТЕРОСКЛЕРОЗОМ КОРОНАРНЫХ АРТЕРИЙ И СОПУТСТВУЮЩИМ САХАРНЫМ ДИАБЕТОМENDOVASCULAR TREATMENT IN PATIENTS WITH ATHEROSCLEROTIC CORONARY STENOSES OF CORONARY ARTERIES AND DIABETES MELLITUSЛешкевичК. Ф.LeshkevichCh. F.noemail@neicon.ruКовшЕ. В.KovshE. V.noemail@neicon.ruПетровЮ. П.PetrovJ. P.noemail@neicon.ruБеймановА. Э.BeimanovA. E.noemail@neicon.ruЧерноглазП. Ф.ChernoglazP. F.noemail@neicon.ruРеспубликанский научно-практический центр «Кардиология»Republican Research and Practical Centre of Cardiology20072809200703712Copyright © Лешкевич К.Ф., Ковш Е.В., Петров Ю.П., Бейманов А.Э., Черноглаз П.Ф., 20072007Лешкевич К.Ф., Ковш Е.В., Петров Ю.П., Бейманов А.Э., Черноглаз П.Ф.Leshkevich C.F., Kovsh E.V., Petrov J.P., Beimanov A.E., Chernoglaz P.F.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.gsmu.by/jour/article/view/559

Целью данного анализа является систематизация исследований эффективности использования различных стентов у больных со стенозирующим атеросклерозом коронарных артерий и сопутствующим сахарным диабетом.

The Aim of this analysis is systematization of trials different stents in patient with atherosclerotic coronary stenoses of coronary arteries and diabetes mellitus.

сахарный диабетрестенозимплантация коронарных стентовстенты без медикаментозного покрытиястенты с медикаментозным покрытиемстентыпокрытые сиролимусомстентыпокрытые паклитакселемисследованияdiabetes mellitusrestenosiscoronary stents implantationbare-metal stent (BMS)drug-eluting stent (DES)Sirolimus-Eluting stentPaclitaxel-Eluting stenttrialsReferencesBonow, R. O. The diabetes epidemic.a national and global crisis / R. O. Bonow, M. Gheorghiade // Am J. Med. - 2004. - Vol. 116, № 5A. - Р. 2-10.Bonow, R. O. The diabetes epidemic.a national and global crisis / R. O. Bonow, M. Gheorghiade // Am J. Med. - 2004. - Vol. 116, № 5A. - Р. 2-10.Smith, S. C. Diabetes and cardiovascular disease writing group VI: revascularization in diabetic patients / R. O. Bonow [et al.] // Circulation. - 2002. - Vol. 105. - Р. 165-l69.Smith, S. C. Diabetes and cardiovascular disease writing group VI: revascularization in diabetic patients / R. O. Bonow [et al.] // Circulation. - 2002. - Vol. 105. - Р. 165-l69.Батыралиев, Т. А. Обзор клинических исследований по ишемической болезни сердца и ее инвазивному лечению / Т. А. Батыралиев, И. В. Першуков // Кардиология. - 2002. - № 5. - С. 68-70.Батыралиев, Т. А. Обзор клинических исследований по ишемической болезни сердца и ее инвазивному лечению / Т. А. Батыралиев, И. В. Першуков // Кардиология. - 2002. - № 5. - С. 68-70.Козлов, С. Г. Эндоваскулярная реваскуляризация миокарда у больных сахарным диабетом / К. Н. Петрова // Кардиология. - 2006. - № 9. - С. 57-66.Козлов, С. Г. Эндоваскулярная реваскуляризация миокарда у больных сахарным диабетом / К. Н. Петрова // Кардиология. - 2006. - № 9. - С. 57-66.Randomized Comparison of Sirolimus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic Patients. The Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial / M. Sabate [et al.] // Circulation. - 2005. - Vol. 112. - Р. 2175-2183.Randomized Comparison of Sirolimus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic Patients. The Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial / M. Sabate [et al.] // Circulation. - 2005. - Vol. 112. - Р. 2175-2183.Impact of sirolimus eluting stents on outcome in diabetic patients. A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy / I. Moussa [et al.] // Circulation. - 2004. - Vol. 109. - Р. 2273-2278.Impact of sirolimus eluting stents on outcome in diabetic patients. A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy / I. Moussa [et al.] // Circulation. - 2004. - Vol. 109. - Р. 2273-2278.Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial / A. Abizaid [et al.] // Eur Heart J. - 2004. - Vol. 25. - Р. 107-112.Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial / A. Abizaid [et al.] // Eur Heart J. - 2004. - Vol. 25. - Р. 107-112.Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis / G. S. Werner [et al.] // Catheter Cardiovasc Interv. - 2004. - Vol. 63. - Р. 259-264.Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis / G. S. Werner [et al.] // Catheter Cardiovasc Interv. - 2004. - Vol. 63. - Р. 259-264.Colombo, A. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions / A. Colombo, J. Drzewiecki, A. Banning et al. for the TAXUS II Study Group // Circulation. - 2003. - Vol. 108. - Р. 788-794.Colombo, A. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions / A. Colombo, J. Drzewiecki, A. Banning et al. for the TAXUS II Study Group // Circulation. - 2003. - Vol. 108. - Р. 788-794.TAXUS IV Investigators. Outcomes with the polymer-based paclitaxel-eluting TAXUS stem in patients with diabetes mellitus: the TAXUS IV trial / J. B. Hermiller [et al.] // J Am Coll Cardiol. - 2005. - Vol. 45. - P. 1172-1179.TAXUS IV Investigators. Outcomes with the polymer-based paclitaxel-eluting TAXUS stem in patients with diabetes mellitus: the TAXUS IV trial / J. B. Hermiller [et al.] // J Am Coll Cardiol. - 2005. - Vol. 45. - P. 1172-1179.Gilbert, J. Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting Diabetes Care / J. Gilbert, J. Raboud, B. Zinman // Circulation. - 2004. - Vol. 27. - Р. 990-994.Gilbert, J. Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting Diabetes Care / J. Gilbert, J. Raboud, B. Zinman // Circulation. - 2004. - Vol. 27. - Р. 990-994.Sousa, J. E. New frontiers in cardiology: drug-eluting stents: part I / J. E. Sousa, P. W. Serruys, M. A. Costa // Circulation. - 2003. - Vol. 107. - Р. 2274-2279.Sousa, J. E. New frontiers in cardiology: drug-eluting stents: part I / J. E. Sousa, P. W. Serruys, M. A. Costa // Circulation. - 2003. - Vol. 107. - Р. 2274-2279.Sousa, J. E. New frontiers in cardiology: drug-eluting stents: part II / J. E. Sousa, P. W. Serruys, M. A. Costa // Circulation. - 2003. - Vol. 107. - Р. 2383-2389.Sousa, J. E. New frontiers in cardiology: drug-eluting stents: part II / J. E. Sousa, P. W. Serruys, M. A. Costa // Circulation. - 2003. - Vol. 107. - Р. 2383-2389.ISAR-DIABETES Study Investigators, Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients / A. Dibra [et al.] // N Engl J Med. - 2005. - Vol. 353. - Р. 663-670.ISAR-DIABETES Study Investigators, Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients / A. Dibra [et al.] // N Engl J Med. - 2005. - Vol. 353. - Р. 663-670.ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs. balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial / A. Kastrati [et al.] // JAMA. - 2005. - Vol. 293. - P. 165-171.ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs. balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial / A. Kastrati [et al.] // JAMA. - 2005. - Vol. 293. - P. 165-171.A Randomized Comparison of Sirolimus-Eluting versus Paclitaxel-Eluting Coronary Artery Stents: 8-Month Results of the REALITY Study / M. C. Morice [et al.] for the REALITY trial Investigators. // JAMA In Review.A Randomized Comparison of Sirolimus-Eluting versus Paclitaxel-Eluting Coronary Artery Stents: 8-Month Results of the REALITY Study / M. C. Morice [et al.] for the REALITY trial Investigators. // JAMA In Review.Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stem implantation in the «real world»: the Rapamycin-eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) registry / P. A. Lemos [et al.] // Circulation. - 2004. - Vol. 109. - P. 190-195.Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stem implantation in the «real world»: the Rapamycin-eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) registry / P. A. Lemos [et al.] // Circulation. - 2004. - Vol. 109. - P. 190-195.Windecker, S. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization / S. Windecker [et al.] // N Engl J Med. - 2005. - Vol. 353. - P. 653-662.Windecker, S. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization / S. Windecker [et al.] // N Engl J Med. - 2005. - Vol. 353. - P. 653-662.Wood, S. Day1: FDA panel accepts stent thrombosis but rejects increased death/MI risk for on-label DES use. http://www.theheart.org/article/759327.; http://www.medscape. com/viewarticle/549048. Date of access: 07.07.2007.Wood, S. Day1: FDA panel accepts stent thrombosis but rejects increased death/MI risk for on-label DES use. http://www.theheart.org/article/759327.; http://www.medscape. com/viewarticle/549048. Date of access: 07.07.2007.

The authors declare that there are no conflicts of interest present.